文献
J-GLOBAL ID:202202220906989973
整理番号:22A0860253
DREAMからREALITI-Aまで:好酸球駆動疾患の治療のためのメポリズマブ【JST・京大機械翻訳】
From DREAM to REALITI-A and beyond: Mepolizumab for the treatment of eosinophil-driven diseases
著者 (15件):
Pavord Ian D.
(Nuffield Department of Medicine and Oxford Respiratory NIHR BRC, University of Oxford, Oxford, UK)
,
Bel Elisabeth H.
(Department of Respiratory Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands)
,
Bourdin Arnaud
(INSERM 12, F-CRIN, Clinical Research Initiative In Severe Asthma: a Lever for Innovation & Science (CRISALIS), France)
,
Bourdin Arnaud
(Service de Pneumologie and INSERM CNRS, CHU Montpellier, Universite de Montpellier, Montpellier, France)
,
Chan Robert
(Clinical Sciences, GSK R&D, Stockley Park, UK)
,
Han Joseph K.
(Department of Otolaryngology, Head & Neck Surgery, Eastern Virginia Medical School, Norfolk, Virginia, USA)
,
Keene Oliver N.
(Biostatistics, GSK, Brentford, UK)
,
Liu Mark C.
(Divisions of Allergy and Clinical Immunology, Pulmonary and Critical Care Medicine, Johns Hopkins Asthma and Allergy Center, Baltimore, MD, USA)
,
Martin Neil
(Global Medical Affairs, GSK, Brentford, UK)
,
Martin Neil
(Institute for Lung Health, University of Leicester, Leicester, UK)
,
Papi Alberto
(Research Center on Asthma and COPD, University of Ferrara, Ferrara, Italy)
,
Roufosse Florence
(Department of Internal Medicine, Hopital Erasme, Universite Libre de Bruxelles, Brussels, Belgium)
,
Steinfeld Jonathan
(Respiratory Research & Development, GSK, Collegeville, PA, USA)
,
Wechsler Michael E.
(Department of Medicine, National Jewish Health Cohen Family Asthma Institute, Denver, CO, USA)
,
Yancey Steven W.
(Respiratory Therapeutic Area Unit, GSK, Research Triangle Park, NC, USA)
資料名:
Allergy
(Allergy)
巻:
77
号:
3
ページ:
778-797
発行年:
2022年
JST資料番号:
E0643B
ISSN:
0105-4538
資料種別:
逐次刊行物 (A)
記事区分:
文献レビュー
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)